Bone marrow mesenchymal stem cells-derived exosomes for penetrating and targeted chemotherapy of pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) is one of the most intractable malignancy, with an only 6% 5-year relative survival rate. The dismal therapeutic effect is attributed to the chemotherapy resistance and unique pathophysiology with abundant inflammatory cytokines and abnormal hyperplasia of ext...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Acta Pharm Sin B
Päätekijät: Zhou, Yu, Zhou, Wenxi, Chen, Xinli, Wang, Qingbing, Li, Chao, Chen, Qinjun, Zhang, Yu, Lu, Yifei, Ding, Xiaoyi, Jiang, Chen
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier 2020
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7488356/
https://ncbi.nlm.nih.gov/pubmed/32963950
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.apsb.2019.11.013
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia